"preoperative 5 fu based chemoradiation" trang 10 - tải miễn phí từ tailieunhanh
Imaging biomarkers for well and moderate hepatocellular carcinoma: Preoperative magnetic resonance image and histopathological correlation

Imaging biomarkers for well and moderate hepatocellular carcinoma: Preoperative magnetic resonance image and histopathological correlation
10    86    0
Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: Patients with stage III colon or stage II/III rectal cancer
15    64    0
Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy
8    72    0
Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: A retrospective study

Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: A retrospective study
11    63    0
Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma

Survival and prognostic analysis of preoperative inflammatory markers in patients undergoing surgical resection for laryngeal squamous cell carcinoma
9    93    0
The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer

The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer
6    63    0
Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears

Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears
14    55    0
MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer

MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer
11    29    1
The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer

The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer
8    63    1
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
10    51    1
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
8    30    1
Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: A propensity score matching analysis

Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: A propensity score matching analysis
11    47    1
Basic Clinical Anesthesia: Part 1

Basic Clinical Anesthesia: Part 1
311    59    1
Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy

Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy
10    64    1
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma

A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma
8    71    1
Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy

Long-term outcomes and significance of preoperative lymphocyte-to-monocyte ratio as a prognostic indicator in patients with invasive pancreatic neoplasms after repeat pancreatectomy
9    38    1
The development and validation of a radiomic nomogram for the preoperative prediction of lung adenocarcinoma

The development and validation of a radiomic nomogram for the preoperative prediction of lung adenocarcinoma
10    64    1
Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer

Predicting prognosis according to preoperative chemotherapy response in patients with locally advanced lower rectal cancer
9    24    1
Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: A SEER population-based study

Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: A SEER population-based study
9    29    1
Predictive value of lymphocyte-tomonocyte ratio in the preoperative setting for progression of patients with breast cancer

Predictive value of lymphocyte-tomonocyte ratio in the preoperative setting for progression of patients with breast cancer
9    32    1